UPR vs. UDG, ONT, CLIN, EMIS, INDV, VEC, GNS, SPI, CTH, and CRW
Should you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Oxford Nanopore Technologies (ONT), Clinigen Group (CLIN), EMIS Group (EMIS), Indivior (INDV), Vectura Group (VEC), Genus (GNS), Spire Healthcare Group (SPI), CareTech (CTH), and Craneware (CRW). These companies are all part of the "medical" sector.
Uniphar vs.
UDG Healthcare (LON:UDG) and Uniphar (LON:UPR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership.
In the previous week, Uniphar had 1 more articles in the media than UDG Healthcare. MarketBeat recorded 1 mentions for Uniphar and 0 mentions for UDG Healthcare. UDG Healthcare's average media sentiment score of 0.00 equaled Uniphar'saverage media sentiment score.
Uniphar has a consensus target price of GBX 310, indicating a potential upside of 78.57%. Given Uniphar's stronger consensus rating and higher probable upside, analysts clearly believe Uniphar is more favorable than UDG Healthcare.
Uniphar has a net margin of 1.69% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.91% beat UDG Healthcare's return on equity.
45.3% of Uniphar shares are held by institutional investors. 10.1% of Uniphar shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
UDG Healthcare received 513 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote.
Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.
UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 1.2%. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Uniphar pays out 1,428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Summary
Uniphar beats UDG Healthcare on 13 of the 16 factors compared between the two stocks.
Get Uniphar News Delivered to You Automatically
Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:UPR) was last updated on 1/22/2025 by MarketBeat.com Staff
